Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 9,540 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: HEARTS Clear all

Conditions: Coronary Artery Disease
Interventions: Percutaneous Coronary Intervention (PCI); Procedure
Lead sponsor: Gold, Herman K., MD; Individual
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heart Failure and Reduced Ejection Fraction, Functional Mitral Regurgitation
Interventions: Cardiac MRI; Diagnostic Test
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 5
States / cities: Minneapolis, Minnesota • Charlotte, North Carolina • Cincinnati, Ohio + 2 more

Conditions: Amyotrophic Lateral Sclerosis (ALS), Neuromuscular Diseases
Interventions: Acute Intermittent Hypoxia, Sham Acute Intermittent Hypoxia; Other
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Depressive Disorder, Cardiac Diseases
Interventions: Aerobic and Resistance Exercises, Qigong; Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cardiogenic Shock
Interventions: Sacubitril-Valsartan, Standard Oral Vasodilators; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Incomplete Spinal Cord Injury, Spasticity, Muscle
Interventions: Motor Skill Training (MST), Transcutaneous Spinal Stimulation (TSS); Behavioral · Device
Lead sponsor: Shepherd Center, Atlanta GA; Other
Eligibility: 18 Years to 70 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Parent-Child Relations, Development, Infant, Parenting, Development, Child
Interventions: Circle of Security Parenting, Little Talks; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 8 Months and older
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: College Park, Maryland • Bethlehem, Pennsylvania

Conditions: Coronary Disease, Percutaneous Coronary Intervention, Exercise Test, Myocardial Perfusion Imaging, Cardiac Catheterization
Interventions: No study intervention; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Hypertension
Interventions: Metoprolol succinate, Nebivolol, Non-invasive measurement of Cardiac Output (CO), Endothelial cell collection, Microvascular perfusion assessment using Definity; Drug · Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Acute Kidney Failure
Interventions: Neseritide; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Heart Failure
Interventions: SEEQ, Cardiocom, DocView; Device
Lead sponsor: Atlantic Health System; Other
Eligibility: 55 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
Interventions: Decitabine, Digoxin; Drug
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Atrial Fibrillation
Interventions: Internal Cardioversion, External Cardioversion; Procedure
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years to 99 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Healthy
Interventions: Cardiac MRI; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Coronary Artery Disease, Coronary Stenosis
Interventions: ICA (Invasive Coronary Angiography), OCT, FFR, VFR Analysis; Procedure · Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 28
States / cities: Huntsville, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 22 more

Conditions: Atrial Fibrillation
Interventions: Bupivacaine, Saline; Drug · Other
Lead sponsor: Christopher Connors, MD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Cardiovascular Diseases (CVD)
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2050
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cardiac Disease
Interventions: Not listed
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 89 Years
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Myocardial Ischemia
Interventions: FDG, NH(3); Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Coronary Artery Disease
Interventions: Stenting plus OMT, OMT, Standard of care; Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 21 Years and older
Enrollment: 1,170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 6
States / cities: Palo Alto, California • Stanford, California • Atlanta, Georgia + 3 more

Conditions: Atrial Fibrillation
Interventions: MyTAP oral appliance plus mouth shield; Device
Lead sponsor: Texas A&M University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Sedentary Lifestyle
Interventions: ActivPAL inclinometer, Phone counseling call: Breaking up sitting time, In-person counseling: Breaking up sitting time, Phone counseling call: Healthy living, Tools to prompt standing, In-person counseling: Healthy living; Device · Behavioral · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 55 Years and older · Female only
Enrollment: 254 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Chula Vista, California • San Diego, California

Search by objective public record fields.

Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Qigong Therapy For Heart Device Patients

Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output

Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity

Hands and Hearts Together

Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women

Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients

BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.

Mobile Health Monitoring Solution for Heart Failure Patients

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation

Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

Ischemic Time and Extent of Myocardial Infarction (MI) With Cardiac Magnetic Resonance Imaging (CMRI) in Patients With ST Elevation Myocardial Infarction (STEMI) and Primary Percutaneous Coronary Intervention (PCI) Study

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation

Heart Institute BioRepository (HIBR) for Pediatric Heart Disease

Safety and Clinical Outcomes of Magnetic Resonance Imaging in Patients With Cardiac Implantable Electrical Devices

Frequency Analysis of Coronary Artery Disease

Electromechanical Mapping to Evaluate Heart Muscle

FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT

Effect of Oral Appliance Therapy on Atrial Fibrillation

Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease